Dysregulated Epigenetics of Chordoma: Prognostic Markers and Therapeutic Targets.
Sign Up to like & getrecommendations! Published in 2022 at "Current cancer drug targets"
DOI: 10.2174/1568009622666220419122716
Abstract: Chordoma is a rare, slow-growing sarcoma that is locally aggressive, and typically resistant to conventional chemo- and radiotherapies. Despite its low incidence, chordoma remains a clinical challenge because therapeutic options for chordoma are limited, and… read more here.
Keywords: chordoma prognostic; prognostic markers; dysregulated epigenetics; markers therapeutic ... See more keywords
Ectonucleotidases in Blood Malignancies: A Tale of Surface Markers and Therapeutic Targets
Sign Up to like & getrecommendations! Published in 2019 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2019.02301
Abstract: Leukemia develops as the result of intrinsic features of the transformed cell, such as gene mutations and derived oncogenic signaling, and extrinsic factors, such as a tumor-friendly, immunosuppressed microenvironment, predominantly in the lymph nodes and… read more here.
Keywords: tale surface; markers therapeutic; surface markers; ectonucleotidases blood ... See more keywords
Prevalence of Sarcopenic Obesity in Various Comorbidities, Diagnostic Markers, and Therapeutic Approaches: A Review
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Geriatric Medicine and Research"
DOI: 10.4235/agmr.22.0081
Abstract: The coexistence of sarcopenia and obesity characterizes sarcopenic obesity. In this condition, there is an imbalance between lean and fat mass amounts. It is a prevalent issue that is gaining prevalence among the elderly population.… read more here.
Keywords: sarcopenic obesity; markers therapeutic; prevalence sarcopenic; obesity ... See more keywords